Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Abou El Hosn Cordero Da Silva (Sao Paulo , Brazil), A. Carolina Lima Resende (Sao Paulo , Brazil), E. Viana Mancuzo (Minas Gerais , Brazil), M. Raquel Soares (Sao Paulo, Brazil), M. Auxiliadora Moreira (Goiania, Brazil), P. Miranda Cavalcante Neto (Sao Paulo, Brazil), L. Ferreira Neves Arantes (Goiania, Brazil), R. Célia Carlos Tibana (Sao Paulo, Brazil), F. Maciel De Aguiar Baptista (Salvador, Brazil), T. Senna Galvão Nonato Alves (Salvador, Brazil), K. Mueller Storrer (Curitiba, Brazil), P. Isolani De Oliveira (Sao Paulo, Brazil), F. Maria Pinheiro Machado Nogueira (Sao Paulo, Brazil), R. Boaventura Martins (Sao Paulo, Brazil), S. Lobo Krupok Matias (Sao Paulo, Brazil), V. El Mir Arida (Sao Paulo, Brazil), A. Bezerra Botelho (Sao Paulo, Brazil), B. Leoncio De Moraes Beraldo (Sao Paulo, Brazil), M. Dornfeld Cunha Castro (Sao Paulo, Brazil), C. Yoshito Fukuda (Sao Paulo, Brazil), M. Tenório Cerezoli (Sao Paulo, Brazil), R. Gomes Ferreira (Sao Paulo, Brazil), I. Missrie (Sao Paulo, Brazil), C. Pereira (Sao Paulo, Brazil). Analyses of predictive findings indicative of progressive interstitial lung diseases. 2243

Member's Comments

No comment yet.

Related content which might interest you: The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Prognostic impact of radiological findings in unclassifiable interstitial lung diseases Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 A comparison of MRI findings in cases with progressive massive fibrosis and lung cancer Source: Virtual Congress 2020 – Screening and imaging in lung cancer Year: 2020 Potential causes of acute deterioration in patients with interstitial lung disease Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Unclassifiable interstitial lung disease: predictive factors of mortality and radiologic features Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 The relationship between radiologic findings and lung function impairment in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 Quantitative assessment of lung pathology in interstitial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 243s Year: 2001 Comparison of densitometric and visual scoring in the assessment of severity of idiopathic fibrotic interstitial pneumonias: Preliminary observations Source: International Congress 2015 – New insights into IIPs Year: 2015 Correlation between HRTC appearance and histopathological features in the diagnosis of interstitial lung diseases Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Prognostic significance of pathologically proven chronic fibrosing interstitial lung diseases with a progressive phenotype (PF-ILDs): single center retrospective cohort Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 32: 170-174 Year: 2008 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Interstitial lung involvement in systemic sclerosis. Correlation of HRCT and lung function tests Source: Eur Respir J 2004; 24: Suppl. 48, 487s Year: 2004 The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013